Ask The Docs: the COVID emergency ends, and a new RSV vaccine in the works

After three years and more than a million people lost, the national COVID-19 emergency is officially over. Now, a new vaccine for respiratory syncytial virus, or RSV, could be in use for adults ages 60 and over by the end of the year. What does it all mean? Radio Boston brings in Drs. Sabrina Assoumou and Benjamin Linas for a round of "Ask The Docs."